Guggenheim Maintains Buy on Accenture, Lowers Price Target to $250

Benzinga Newsdesk www.benzinga.com Negative 71.2%

Neg 71.2% Neu 0% Pos 0%

Guggenheim analyst Jonathan Lee maintains Accenture (NYSE:ACN) with a Buy and lowers the price target from $275 to $250.